HIFU for Prostate Cancer: A Minimally Invasive Treatment Option Gains Reimbursement in France For many men, a prostate cancer diagnosis is a frightening experience. In France, nearly 60,000 latest cases …
Tag:
treatment
-
-
Restaurant Owner Nabilah O’Brien Named Suspect in Alleged Food Theft and Defamation Case Jakarta – Nabilah O’Brien, the owner of Bibi Kelinci Kopitiam in Kemang, South Jakarta, has been named …
-
The Global HIV/AIDS Epidemic: An Updated Overview HIV, the virus that causes AIDS (acquired immunodeficiency syndrome), remains one of the world’s most significant public health challenges. Whereas substantial progress has …
-
OEA Supplementation Boosts Gut Health and May Offer Metabolic Benefits Emerging research suggests that oleoylethanolamide (OEA) supplementation may positively influence gut health by increasing levels of beneficial bacteria and improving …
-
Epitranscriptomics: Unlocking the Secrets of RNA Modifications For decades, the central dogma of molecular biology focused on the flow of information from DNA to RNA to protein. However, a growing …
-
Global Breast Cancer Cases Expected to Surge by 2050, Driven by Rising Incidence in Younger Women Breast cancer remains the most commonly diagnosed cancer among women worldwide and a leading …
-
Understanding Metastatic Breast Cancer: A Comprehensive Guide Breast cancer is a complex disease, and while many are familiar with early-stage diagnoses, understanding metastatic breast cancer – when the cancer has …
-
Single Daily Pill Shows Promise as Replacement for Complex HIV Treatment A new, once-daily oral tablet combining bictegravir and lenacapavir (BIC/LEN) may offer a simpler treatment option for people living …
-
Italy Leads Europe in Approving New Therapy for BRAF-Mutated Metastatic Colorectal Cancer Italy has become the first country in Europe to provide national health service access to a new therapeutic …
-
Olaparib Receives Reimbursement for Advanced Pancreatic Cancer with BRCA Mutations The Italian Medicines Agency (AIFA) has approved the reimbursement of olaparib, a PARP inhibitor, for the maintenance treatment of patients …